Transglutaminase 2 protects against ischemic stroke

Neurobiology of Disease

Volumn 39, Issue 3, 2010, Pages 334-343

  Filiano, A J ^a   Tucholski, J ^b   Dolan, P J ^a   Colak, G ^c   Johnson, G V W ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Hypoxia; Hypoxia inducible factor; Ischemia; Neuron; Noxa; Stroke; Transglutaminase 2

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN NOXA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

EID: 77954953233     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.04.018     Document Type: Article

References (63)

1. Aarts M.M., Tymianski M. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr. Mol. Med. 2004, 4:137-147.
2. Ahn J.S., et al. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2008, 376:743-747.
3. Aminova L.R., et al. Prosurvival and prodeath effects of hypoxia-inducible factor-1alpha stabilization in a murine hippocampal cell line. J. Biol. Chem. 2005, 280:3996-4003.
4. Bailey C.D., et al. Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases. Mol. Cell. Neurosci. 2004, 25:493-503.
5. Baranova O., et al. Neuron-specific inactivation of the hypoxia inducible factor 1 α increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci. 2007, 27:6320-6332.
6. Begg G.E., et al. Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19683-19688.
7. Blanquet P.R., et al. Identification of a biphasic signaling pathway involved in ischemic resistance of the hippocampal dentate gyrus. Exp. Neurol. 2006, 202:357-372.
8. Boehm J.E., et al. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J. Biol. Chem. 2002, 277:20127-20130.
9. Campisi A., et al. Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res. 2003, 978:24-30.
10. Chen W., et al. HIF-1α inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol. Dis. 2008, 31:433-441.
11. Chen C., et al. Early inhibition of HIF-1α with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol. Dis. 2009, 33:509-517.
12. Dardik R., Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp. Cell Res. 2006, 312:2973-2982.
13. Dayan F., et al. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res. 2006, 66:3688-3698.
14. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 2002, 27:534-539.
15. Filiano A.J., et al. Transglutaminase 2 protects against ischemic insult, interacts with HIF1β, and attenuates HIF1 signaling. FASEB J. 2008, 22:2662-2675.
16. Fong G.H. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 2008, 11:121-140.
17. Gundemir S., Johnson G.V. Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS ONE 2009, 4:e6123.
18. Guo K., et al. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 2001, 8:367-376.
19. Hagenbuchner J., et al. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J. Biol. Chem. 2010, 285:6904-6912.
20. Halterman M.W., et al. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci. 1999, 19:6818-6824.
21. Hasegawa G., et al. A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem. J. 2003, 373:793-803.
22. Helton R., et al. Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage. J. Neurosci. 2005, 25:4099-4107.
23. Hohenstein B., et al. Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J. Am. Soc. Nephrol. 2005, 16:986-996.
24. Hu C.J., et al. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1α and HIF-2α. Mol. Biol. Cell 2007, 18:4528-4542.
25. Ientile R., et al. Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia. Neurosci. Lett. 2004, 363:173-177.
26. Jang G.Y., et al. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-αB activity in hypoxic tumor cells. Oncogene 2009, 29:356-367.
27. Kasper L.H., Brindle P.K. Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription. Cell Cycle 2006, 5:142-146.
28. Kasper L.H., et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J. 2005, 24:3846-3858.
29. Kim S.Y., et al. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J. Biol. Chem. 1999, 274:30715-30721.
30. Kim J.Y., et al. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 2004, 199:113-124.
31. Lee M.J., et al. Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol. Cell. Biol. 2004, 24:3918-3927.
32. Lesort M., et al. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 1998, 273:11991-11994.
33. Lesort M., et al. Tissue transglutaminase is increased in Huntington's disease brain. J. Neurochem. 1999, 73:2018-2027.
34. Li J., et al. Cell death and proliferation in NF-αB p50 knockout mouse after cerebral ischemia. Brain Res. 2008, 1230:281-289.
35. Liu S., et al. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2743-2747.
36. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 2003, 4:140-156.
37. Maeda K., et al. Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. NeuroReport 1998, 9:1317-1319.
38. Maxwell P.H., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
39. Milakovic T., et al. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J. Biol. Chem. 2004, 279:8715-8722.
40. Mishra S., Murphy L.J. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J. Biol. Chem. 2004, 279:23863-23868.
41. Peng X., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-α3. FEBS Lett. 1999, 446:35-39.
42. Perry M.J., Haynes L.W. Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord. Int. J. Dev. Neurosci. 1993, 11:325-337.
43. Perry M.J., et al. Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking. Neuroscience 1995, 65:1063-1076.
44. Piacentini M., et al. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J. Neurochem. 2002, 81:1061-1072.
45. Pinkas D.M., et al. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007, 5:e327.
46. Rosenberg G.A., et al. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 1992, 576:203-207.
47. Sharp F.R., Bernaudin M. HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 2004, 5:437-448.
48. Sharp F.R., et al. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2000, 20:1011-1032.
49. Siegel M., et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 2008, 3:e1861.
50. Singh U.S., et al. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 1995, 34:15863-15871.
51. Sonmez A., et al. Erythropoietin attenuates neuronal injury and potentiates the expression of pCREB in anterior horn after transient spinal cord ischemia in rats. Surg. Neurol. 2007, 68:297-303. discussion 303.
52. Szondy Z., et al. Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis. Cell Death Differ. 2006, 13:1827-1829.
53. Tamura A., et al. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow. Metab. 1981, 1:53-60.
54. Tang Y., et al. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol. Dis. 2006, 21:18-28.
55. Tolentino P.J., et al. Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats. J. Neurochem. 2004, 89:1301-1307.
56. Tucholski J., Johnson G.V. Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J. Biol. Chem. 2003, 278:26838-26843.
57. Tucholski J., et al. Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage. J. Neurochem. 2006, 97:582-594.
58. Valerio A., et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-αB/c-Rel-dependent transcription. Stroke 2009, 40:610-617.
59. Van Hoecke M., et al. Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia. Mol. Cell. Neurosci. 2007, 34:40-47.
60. Vangeison G., et al. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J. Neurosci. 2008, 28:1988-1993.
61. 2 tension. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:5510-5514.
62. Warnecke C., et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J. 2004, 18:1462-1464.
63. Wilhelmus M.M., et al. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol. 2009, 19:612-622.